Cumberland Emerging Technologies (CET) in Nashville today announced its collaboration with the University of Tennessee Research Foundation (UTRF) to pursue commercialization of a drug that may mitigate or even prevent asthma in children. The principal investigator on the drug is the UT College of Medicine's Dr. Dukhee Betty Lew.
Tuesday, February 10, 2009
Cumberland Emerging Technologies allies with UT Research Foundation
Cumberland Emerging Technologies (CET) in Nashville today announced its collaboration with the University of Tennessee Research Foundation (UTRF) to pursue commercialization of a drug that may mitigate or even prevent asthma in children. The principal investigator on the drug is the UT College of Medicine's Dr. Dukhee Betty Lew.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment